Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty
Prospective Randomized Trial Comparing Topical Tranexamic Acid Plus Standard Of Care Versus Standard Of Care For The Reduction Of Blood Loss Following Primary Total Hip Arthroplasty Surgery
Sponsor: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Listed as NCT01260818, this NA trial focuses on Hip Replacement and Postoperative Hemorrhage and remains ongoing. Sponsored by The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
For direct contact, visit the study record on ClinicalTrials.gov .